Zobrazeno 1 - 7
of 7
pro vyhledávání: '"59"'
Autor:
Franklin H. Epstein, Cong Qian, Kai F. Yu, Richard J. Levine, S. Ananth Karumanchi, Sharon Maynard
Publikováno v:
American Journal of Obstetrics and Gynecology. 194:1034-1041
Objective The purpose of this study was to determine whether serum fms-like tyrosine kinase 1 (sFlt1) concentration during preeclampsia were associated with mid trimester blood pressure, other maternal characteristics, or pregnancy outcomes. Study de
Autor:
Jianguo Xia, Edison Dong, Kypros H. Nicolaides, David S. Wishart, Rupasri Mandal, Michael Kruger, Ray O. Bahado-Singh, Ranjit Akolekar
Publikováno v:
American journal of obstetrics and gynecology. 208(1)
Objective We sought to identify first-trimester maternal serum biomarkers for the prediction of late-onset preeclampsia (PE) using metabolomic analysis. Study Design In a case-control study, nuclear magnetic resonance–based metabolomic analysis was
Publikováno v:
American journal of obstetrics and gynecology. 188(1)
Objective: The aim of the current study was to investigate levels of placenta growth factor in the tissues and sera of the patients with gestational trophoblastic disease and to determine its usefulness for the treatment of gestational trophoblastic
Autor:
Brian K. Rinehart, Dom A. Terrone, James N. Martin, William A. Bennett, Joey P. Granger, Sallah Kassab
Publikováno v:
American journal of obstetrics and gynecology. 182(6)
Objective: This study was designed to examine the effects of intrauterine endotoxin (lipopolysaccharide) on rat pregnancy. Study Design: Pregnant Sprague-Dawley rats (N = 26) were implanted with uterine catheters on day 15 or 16 of a 22-day gestation
Autor:
Sharon Maynard, Jing Yan, Melissa J. Moore, Laura Robidoux, Tiffany A. Moore Simas, Susanne L. Bathgate, Sybil L. Crawford
Publikováno v:
American Journal of Obstetrics and Gynecology. 209:53.e1-53.e9
Objective Several conditions are associated with increased preeclampsia (PE) risk. Whether altered maternal angiogenic factor levels contribute to risk in these conditions is unknown. Our objective was to compare angiogenic biomarker patterns in high
Publikováno v:
American Journal of Obstetrics and Gynecology. 159:891-895
Corticotropin-releasing hormone was discovered in the placenta, and its concentration in the maternal plasma was found to increase greatly during the latter half of pregnancy. We studied the concentration of immunoreactive corticotropin-releasing hor
Publikováno v:
American journal of obstetrics and gynecology. 139(4)
Adrenocorticotropin (ACTH) and cortisol in plasma were measured weekly from early in gestation through delivery in five women whose pregnancies were normal. During the twelfth week of pregnancy, the concentration of ACTH in plasma of blood samples ob